
FDA approves Moderna's mRNA flu vaccine for adults 50 and older
The FDA approved Moderna's mRNA-based seasonal influenza vaccine, mFLUSIVA, for adults 50 and older. It is the first flu vaccine using COVID-19 shot technology and will be available in weeks.
